Literature DB >> 11290418

Identification and characterization of the human MOG1 gene.

K A Marfatia1, M T Harreman, P Fanara, P M Vertino, A H Corbett.   

Abstract

Many of the proteins that mediate transport into and out of the nucleus have been structurally and functionally conserved throughout evolution. Here we describe the sequence and characterization of the human MOG1 gene. The MOG1 gene was originally identified in Saccharomyces cerevisiae as a multi-copy suppressor of conditional alleles of the yeast nuclear transport factor, GSP1 (scRan) (Oki and Nishimoto (1998) Proc. Natl. Acad. Sci. USA 95, 15388-15393). A search of the expressed sequence tag database identified a putative human protein that is 29% identical and 47% similar to the yeast protein. Our experiments demonstrate that the human MOG1 message is expressed in a variety of tissue samples. Several experiments indicate that the human MOG1 protein binds to both yeast and human Ran suggesting functional conservation between the yeast and human MOG1 proteins. Furthermore, hMOG1a, like scMOG1, is localized throughout the cell but is concentrated within the nucleus. Consistent with these findings, hMOG1a can partially complement the growth defect present in yeast MOG1 deletion cells. Taken together, our findings suggest that MOG1 is an evolutionarily conserved Ran binding protein that could play a role in regulating nuclear protein trafficking.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290418     DOI: 10.1016/s0378-1119(01)00364-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Diseases caused by mutations in Nav1.5 interacting proteins.

Authors:  John W Kyle; Jonathan C Makielski
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

2.  Role for the Ran binding protein, Mog1p, in Saccharomyces cerevisiae SLN1-SKN7 signal transduction.

Authors:  Jade Mei-Yeh Lu; Robert J Deschenes; Jan S Fassler
Journal:  Eukaryot Cell       Date:  2004-12

Review 3.  Ankyrin-based cellular pathways for cardiac ion channel and transporter targeting and regulation.

Authors:  Shane R Cunha; Peter J Mohler
Journal:  Semin Cell Dev Biol       Date:  2010-10-08       Impact factor: 7.727

4.  Mechanistic insights into the interaction of the MOG1 protein with the cardiac sodium channel Nav1.5 clarify the molecular basis of Brugada syndrome.

Authors:  Gang Yu; Yinan Liu; Jun Qin; Zhijie Wang; Yushuang Hu; Fan Wang; Yabo Li; Susmita Chakrabarti; Qiuyun Chen; Qing Kenneth Wang
Journal:  J Biol Chem       Date:  2018-10-03       Impact factor: 5.157

Review 5.  Channelopathies from mutations in the cardiac sodium channel protein complex.

Authors:  Graham S Adsit; Ravi Vaidyanathan; Carla M Galler; John W Kyle; Jonathan C Makielski
Journal:  J Mol Cell Cardiol       Date:  2013-04-01       Impact factor: 5.000

6.  Suppressor of fused regulates Gli activity through a dual binding mechanism.

Authors:  Mark Merchant; Felix F Vajdos; Mark Ultsch; Henry R Maun; Ulrich Wendt; Jennifer Cannon; William Desmarais; Robert A Lazarus; Abraham M de Vos; Frederic J de Sauvage
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

7.  Cardiac sodium channel regulator MOG1 regulates cardiac morphogenesis and rhythm.

Authors:  Juan Zhou; Longfei Wang; Mengxia Zuo; Xiaojing Wang; Abu Shufian Ishtiaq Ahmed; Qiuyun Chen; Qing K Wang
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

Review 8.  Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

Authors:  Gildas Loussouarn; Damien Sternberg; Sophie Nicole; Céline Marionneau; Francoise Le Bouffant; Gilles Toumaniantz; Julien Barc; Olfat A Malak; Véronique Fressart; Yann Péréon; Isabelle Baró; Flavien Charpentier
Journal:  Front Pharmacol       Date:  2016-01-14       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.